These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8905670)

  • 1. Opioid receptor independent inhibition of Ca2+ and K+ currents in NG108-15 cells by the kappa opioid receptor agonist U50488H.
    Carpenter E; Gent JP; Peers C
    Neuroreport; 1996 Jul; 7(11):1809-12. PubMed ID: 8905670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
    Utz J; Eckert R; Trautwein W
    J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
    Berecki G; Motin L; Adams DJ
    Neuropharmacology; 2016 Oct; 109():49-58. PubMed ID: 27245500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kappa-opiate agonist U50488H decreases the entry of 45Ca into rat cortical synaptosomes by inhibiting N- but not L-type calcium channels.
    Xiang JZ; Adamson P; Brammer MJ; Campbell IC
    Neuropharmacology; 1990 May; 29(5):439-44. PubMed ID: 2162495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual modulation of GIRK1/GIRK2 channels by opioid receptor ligands.
    Ulens C; Daenens P; Tytgat J
    Eur J Pharmacol; 1999 Dec; 385(2-3):239-45. PubMed ID: 10607882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
    Suarez-Roca H; Maixner W
    J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of U50488H on potassium currents of acutely isolated mouse hippocampal CA3 pyramidal neurons.
    Zou BD; OuYang KF; Chen YZ; Wu CH; Zhou PA
    Brain Res; 2001 Apr; 897(1-2):52-9. PubMed ID: 11282358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An electrophysiological basis for the antiarrhythmic actions of the kappa-opioid receptor agonist U-50,488H.
    Pugsley MK; Saint DA; Walker MJ
    Eur J Pharmacol; 1994 Aug; 261(3):303-9. PubMed ID: 7813552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide reverses the kappa-opioid-receptor-mediated depression of calcium current in rat dorsal root ganglion neurons.
    Xu T; Liu NJ; Li CQ; Shangguan Y; Yu YX; Kang HG; Han JS
    Brain Res; 1996 Aug; 730(1-2):207-11. PubMed ID: 8883905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.
    Jin W; Lee NM; Loh HH; Thayer SA
    Mol Pharmacol; 1992 Dec; 42(6):1083-9. PubMed ID: 1336113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Ca2+ channel current by mu- and kappa-opioid receptors coexpressed in Xenopus oocytes: desensitization dependence on Ca2+ channel alpha 1 subunits.
    Kaneko S; Yada N; Fukuda K; Kikuwaka M; Akaike A; Satoh M
    Br J Pharmacol; 1997 Jun; 121(4):806-12. PubMed ID: 9208152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of U50488H on sodium currents in acutely isolated mice hippocampal CA3 pyramidal neurons.
    Zou B; Chen Y; Wu C; Zhou P
    Brain Res; 2000 Feb; 855(1):132-6. PubMed ID: 10650139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ channel inhibition by kappa opioid receptors expressed in Xenopus oocytes.
    Kaneko S; Fukuda K; Yada N; Akaike A; Mori Y; Satoh M
    Neuroreport; 1994 Dec; 5(18):2506-8. PubMed ID: 7535119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine 3',5'-cyclic monophosphate-stimulated Ca++ efflux and acetylcholine release in ileal myenteric plexus are mediated by N-type Ca++ channels: inhibition by the kappa opioid receptor agonist.
    Kojima Y; Tsunoda Y; Owyang C
    J Pharmacol Exp Ther; 1997 Jul; 282(1):403-9. PubMed ID: 9223581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional couplings of the delta- and the kappa-opioid receptors with the G-protein-activated K+ channel.
    Ikeda K; Kobayashi T; Ichikawa T; Usui H; Kumanishi T
    Biochem Biophys Res Commun; 1995 Mar; 208(1):302-8. PubMed ID: 7887943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels.
    Kojima Y; Takahashi T; Fujina M; Owyang C
    J Pharmacol Exp Ther; 1994 Feb; 268(2):965-70. PubMed ID: 8114012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-opioid agonist U50488 inhibits P-type Ca2+ channels by two mechanisms.
    Kanemasa T; Asakura K; Ninomiya M
    Brain Res; 1995 Dec; 702(1-2):207-12. PubMed ID: 8846078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilization of intracellular Ca2+ and stimulation of cyclic AMP production by kappa opioid receptors expressed in Xenopus oocytes.
    Kaneko S; Nakamura S; Adachi K; Akaike A; Satoh M
    Brain Res Mol Brain Res; 1994 Dec; 27(2):258-64. PubMed ID: 7898309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of U50,488H on transient outward and ultra-rapid delayed rectifier K+ currents in young human atrial myocytes.
    Xiao GS; Zhou JJ; Cheung YF; Li GR; Wong TM
    Eur J Pharmacol; 2003 Jul; 473(2-3):97-103. PubMed ID: 12892826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the kappa agonist U50488H has non-opioid actions.
    Hayes AG; Birch PP; Cavicchini E
    J Pharm Pharmacol; 1988 Oct; 40(10):718-20. PubMed ID: 2907540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.